Published:
Key Takeaways
- Blue Goat Cyber attends SWITCH Singapore 2025 to discuss medical device cybersecurity.
- CEO Christian Espinosa emphasizes cybersecurity's role in patient safety and market advantage.
- VP Melissa Espinosa highlights cybersecurity as crucial for earning trust and credibility.
- Blue Goat Cyber offers end-to-end cybersecurity solutions with an FDA cybersecurity submission deficiency commitment.
- 275+ FDA submissions supported, zero cybersecurity rejections.
SINGAPORE, October 27, 2025 - Blue Goat Cyber, the global authority in medical device cybersecurity and regulatory compliance, will attend the Singapore Week of Innovation and Technology (SWITCH) 2025, Asia’s leading event for innovators, investors, and MedTech leaders shaping the future of healthcare technology.
Representing Blue Goat Cyber are Christian Espinosa, CEO, and Melissa Espinosa, VP of Strategic Partnerships. The team is actively scheduling one-on-one meetings with MedTech innovators, manufacturers, and investors to discuss how robust cybersecurity strategies can accelerate regulatory success, patient safety, and global market expansion.